How to assess endothelial function in (secondary) prevention

5 November 2018

Organised by:

The aim of this article is to summarise the most common methods employed in clinical practice.

References

1. ESC Committee for Practical Guidelines. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). Eur Heart J 2012; 33:1635-1701.
2. Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery. A report of the International Brachial Artery Reactivity Task Force. J AmCollCardiol 2002;39:257–265.
3. Tortoli, P, Palombo C, Ghiadoni L, et al. Simultaneous ultrasound assessment of brachial artery shear stress stimulus and flow-mediated dilation during reactive hyperemia. Ultrasound in Med. & Biol. 2011;10: 1561–1570.
4. Sorensen KE, Celermajer DS, Spegelhalter DJ, et al.Noninvasive measurement of human endothelium dependent arterial responses: Accuracy and reproducibility. Br Heart J 1995;74:247–253.
5. Neunteufl T, Heher S, Katzenschlager R, et al. Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain. Am J Cardiol 2000; 86: 207-210.
6. Heitzer T, Baldus S, von Kodolitsch Y, et al. Systemic endothelial dysfunction as an early predictor of adverse outcome in heart failure. ArteriosclThrombVascBiol 2005;25:1174-1179.
7. Belardinelli R, Mucaj A, Lacalaprice F, et al. Coenzyme Q10 and exercise training in chronic heart failure. Eur Heart J 2006;27:2675–2681.
8. Gokce N, Keaney JF Jr, Hunter LM, et al. Risk stratification of postoperative cardiovascular events via noninvasive assessment of endothelial function: A prospective study. Circulation 2002;105:1567-1572.
9. Belardinelli R, Solenghi M, Volpe L, Purcaro A. Trimetazidineimproves endothelial dysfunction in chronic heart failure : an antioxidant effect. Eur Heart J 2007;27:1102-1108.
10. Hamburg NM, Keyes MJ, Larson MG, et al. Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study. Circulation 2008;117:2467-2474.
11. NohriaA, Gerhard-Herman M, Creager MA, et al. Role of nitric oxide in the regulation of digital pulse volume amplitude in humans. J ApplPhysiol 2006; 101:545-548.
12. Rubinstein E, Kevin JT, Soffler M, et al. Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events. Eur Heart J 2010;31: 1142-1148.
13. Petrie JR, Ueda S, Morris AD, et al. How reproducible is bilateral forearm plethysmography? Br J ClinPharmacol 1998;45:131-139.
14. Heitzer T, Schlinzig T, Krohn K, et al. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001;104:2673-2678.
15. Benjamin N, Calver A, Collier J, Robinson B, Vallance P, Webb D. Measuring forearm blood flow and interpreting the responses to drugs and mediators. Hypertension1995;25:918 –923.
16. Ludmer PL, Selwyn AP, Shook TL, et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med. 1986;315:1046 –1051.
17. Hambrecht R, Wolf A, Gielen S, et al. Effect of exercise on coronary endothelial function in patients with coronary artery disease. N Engl J Med. 2000;342:454–460.
18. Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med. 2007;356:830–840.